The BlogNotions Life Sciences Newsletter delivers a diverse series of perspectives provided by thought leaders in the life sciences industries. Presented by NetLine, this forum delivers compelling updates on the latest technological advances, discussio…
 |
Companies that can demonstrate patient outcomes will hold a distinct competitive advantage. To gain that advantage, they must know how to comply with HIPAA rule – or better yet, find a partner that can navigate and help them achieve this compliance. As it happens, another market force is driving ease in securing, storing and analyzing the data needed for collaborative research projects – the switch to highly scalable cloud technologies and services. Download this white paper to learn more today. |
 |
Companies that can demonstrate patient outcomes will hold a distinct competitive advantage. To gain that advantage, they must know how to comply with HIPAA rule – or better yet, find a partner that can navigate and help them achieve this compliance. As it happens, another market force is driving ease in securing, storing and analyzing the data needed for collaborative research projects – the switch to highly scalable cloud technologies and services. Download this white paper to learn more today. |
Summary Points:Meaningful use is an incentive program sponsored by the US federal government that has provided more than US$25 billion to date to incentivize US healthcare clinics and hospitals to implement electronic health records (EHRs). Healthcare …
Summary PointsTime-sensitive access to unapproved experimental interventions should be permitted on humanitarian grounds when patients or communities are facing death or irreversible disease progression and no other efficacious diagnostic, preventive, …
Summary Points:The evidence base underpinning clinical practice is deeply flawed.There must be better value gained from resources invested in medical research.We make four proposals: (1) introducing publications officers; (2) developing core comp…
Summary Points:Historically, the impact of many health professional training initiatives in low-income countries has been limited by narrow focus on a small set of diseases, inefficient utilization of donor funding, inadequate scale up, insufficient em…
Summary PointsThe international response to the West African Ebola virus disease epidemic has exemplified the great potential of the global public health community. However, the protracted early response also revealed critical gaps, which likely result…
Summary Points:Spending on brand-name prescription medications, particularly brand-name biologic drugs, continues to increase.Considerable savings and improvements in medication adherence are possible from greater use of more affordable generic drugs a…
This recent research identifies current and emerging regulatory and compliance needs of biotechnology, pharmaceutical, and medical device companies, as well as key capabilities to manage and govern the staggering volume of sensitive information beyond …
